Study on miRNAs’ Expression for the Invasion of Pituitary Adenomas

Objective & Hypothesis:AIM: To explore the possible invasive effect of four microRNAs (miRNAs) in invasive pituitary adenomas.MATERIAL and METHODS: Based on our previous studies, several in silico algorithms, and relative literature, 30 Han Chinesepatients with invasive pituitary adenomas and 30 with non-invasive pituitary adenomas were involved in this research.

📊

Key Findings & Data:The proteinsrelated to invasion underwent immunohistochemical staining, including basic fibroblast growth factor (FGF2), pituitary tumortransforming gene (PTTG), cyclin B1 (CCNB1), survivin, focal adhesion kinase (FAK), and microvessel density (MVD).

💡

Conclusion & Impact:The results indicated some relationship between the miRNA and protein expression during the pituitary invasionprocess.

🔬Design:Review & Systematic Survey

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

AIM: To explore the possible invasive effect of four microRNAs (miRNAs) in invasive pituitary adenomas.MATERIAL and METHODS: Based on our previous studies, several in silico algorithms, and relative literature, 30 Han Chinesepatients with invasive pituitary adenomas and 30 with non-invasive pituitary adenomas were involved in this research. The proteinsrelated to invasion underwent immunohistochemical staining, including basic fibroblast growth factor (FGF2), pituitary tumortransforming gene (PTTG), cyclin B1 (CCNB1), survivin, focal adhesion kinase (FAK), and microvessel density (MVD). To validatethe effect of miRNAs, miR-24, miR-93, miR-126, and miR-34a were chosen as possible targets for the aforementioned proteinswith four in silico algorithms. All miRNAs tests were performed using quantitative real-time polymerase chain reaction (qPCR). Theexpression levels of proteins and miRNAs associated with tumors’ invasiveness were analyzed.RESULTS: In our study, FGF2, FAK, PTTG, CCNB1, and MVD were overexpressed in the invasive group compared with the noninvasive group, while an increase in the expression of survivin in the invasive group did not achieve statistical significance. Thispaper reviewed the literature, and four miRNAs involving invasion were selected for study: miR-24, miR-34a, miR-93, and miR-126.Under-expression of miR-24, miR-34a, and miR-93 was significant in the invasive group, while a decrease of miR-126 expressionin the invasive group did not achieve statistical significance.CONCLUSION: FGF2, PTTG, CCNB1, survivin, FAK, and MVD proteins of pituitary adenoma showed strong expression in invasivetumors. Furthermore, miR-24, miR-93, miR-34a, and miR-126 were under-expressed in invasive Pituitary adenomas compared withnon-invasive ones. The results indicated some relationship between the miRNA and protein expression during the pituitary invasionprocess.

🔖

Cite This Article

ZHANG, Y., YU, G., WANG, H., YU, S., LI, C., BAI, J., GUI, S., ZHAO, P. (2022). Study on miRNAs’ Expression for the Invasion of Pituitary Adenomas. Turkish Neurosurgery, Cilt: 28 - Sayı: 4, 530–537. https://ajindex.com/articles/616963

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microRNA.org resource: Targets and expression. Nucleic Acids Res 36: D149-D153, 2007
Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC: Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210: 370-377, 2007
Butz H, Liko I, Czirjak S, Igaz P, Khan MM, Zivkovic V, Balint K, Korbonits M, Racz K, Patocs A: Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab 95: E181-191, 2010
Cao W, Fan R, Wang L, Cheng S, Li H, Jiang J, Geng M, Jin Y, Wu Y: Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumour Biol 34: 963- 971, 2013
Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C: Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 5: 11873-11885, 2014
Chen R, Liu H, Cheng Q, Jiang B, Peng R, Zou Q, Yang W, Yang X, Wu X, Chen Z: MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide. Biol Open 5:669-677, 2016
Chen S, Chen X, Sun KX, Xiu YL, Liu BL, Feng MX, Sang XB, Zhao Y: MicroRNA-93 promotes epithelial-mesenchymal transition of endometrial carcinoma cells. PLoS One 11: e0165776, 2016
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, Tsai TR, Ho SY, Jian TY, Wu HY, Chen PR, Lin NC, Huang HT, Yang TL, Pai CY, Tai CS, Chen WL, Huang CY, Liu CC, Weng SL, Liao KW, Hsu WL, Huang HD: miRTarBase 2016: Updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 44: D239-D247, 2016 D’Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A: Altered microRNA expression profile in human pituitary GH adenomas: Down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97: E1128-1138, 2012
Denes J, Kasuki L, Trivellin G, Colli LM, Takiya CM, Stiles CE, Barry S, de Castro M, Gadelha MR, Korbonits M: Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. PloS One 10: e0117107, 2015
Ehrlich L, Hall C, Venter J, Dostal D, Bernuzzi F, Invernizzi P, Meng F, Trzeciakowski JP, Zhou T, Standeford H, Alpini G, Lairmore TC, Glase